Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
36.31
0.29 (0.81%)
At close: Aug 15, 2025, 3:44 PM

Revolution Medicines Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-12.23 -7.44 -7.72 -10.19
PEG Ratio
1.69 -0.29 -0.31 -0.19
PS Ratio
n/a 280.24 54.28 62.35
PB Ratio
3.24 1.78 2.80 3.04
P/FCF Ratio
-12.92 -9.06 -8.16 -11.92
P/OCF Ratio
-13.16 -9.26 -8.56 -12.45
OCF/S Ratio
n/a -30.27 -6.34 -5.01
Debt / Equity Ratio
0.06 0.05 0.09 0.11
Quick Ratio
14.20 13.06 10.65 31.15
Current Ratio
14.20 13.06 10.65 30.48
Asset Turnover
n/a 0.01 0.04 0.04
Interest Coverage
n/a -1.61K n/a -15.67K
Return on Equity
-0.26 -0.24 -0.36 -0.3
Return on Assets
-0.23 -0.21 -0.31 -0.24
Return on Invested Capital
-0.29 -0.25 -0.34 -0.25
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 1.00 0.73 0.75
Net Profit Margin
n/a -37.68 -7.03 -6.12
Pretax Profit Margin
n/a -37.99 -7.04 -6.37
Operating Profit Margin
n/a -42.07 -7.3 -6.4
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -37.18 -6.77 -6.12